Intellia Therapeutics
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. Wikipedia
CRSP (NasdaqGM) $47.30 +0.05 (+0.11%)
Mon, Nov 18, 2024, 4:00PM EST